Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Share-based Compensation (2020 - 2022)

Atea Pharmaceuticals has reported Share-based Compensation over the past 3 years, most recently at $11.6 million for Q4 2022.

  • Quarterly results put Share-based Compensation at $11.6 million for Q4 2022, up 2.59% from a year ago — trailing twelve months through Dec 2022 was $46.7 million (up 17.91% YoY), and the annual figure for FY2025 was $20.7 million, down 59.97%.
  • Share-based Compensation for Q4 2022 was $11.6 million at Atea Pharmaceuticals, up from $11.5 million in the prior quarter.
  • Over the last five years, Share-based Compensation for AVIR hit a ceiling of $11.9 million in Q2 2022 and a floor of $189000.0 in Q1 2020.
  • Median Share-based Compensation over the past 3 years was $10.5 million (2021), compared with a mean of $7.8 million.
  • Biggest five-year swings in Share-based Compensation: soared 4688.04% in 2021 and later increased 2.59% in 2022.
  • Atea Pharmaceuticals' Share-based Compensation stood at $2.8 million in 2020, then soared by 302.38% to $11.4 million in 2021, then grew by 2.59% to $11.6 million in 2022.
  • The last three reported values for Share-based Compensation were $11.6 million (Q4 2022), $11.5 million (Q3 2022), and $11.9 million (Q2 2022) per Business Quant data.